Navigation Links
AcroMetrix Announces Launch of First Liquid MRSA Positive Control

BENICIA, Calif., March 25 /PRNewswire/ -- AcroMetrix, a leading provider of quality control products and services for clinical diagnostic laboratories, announced today the launch of the first standardized External Quality Control for Methicillin Resistant Staphylococcus aureas (MRSA) molecular testing. The OptiQual MRSA Positive Control may be used to independently monitor all phases of MRSA DNA testing to ensure consistent and accurate results.

A study published October 2007 in the Journal of the American Medical Association estimated that MRSA infections resulted in the death of 18,650 out of 94,360 infected patients in the United States in 2005 -- death rate higher than that of HIV/AIDS in the same year. Since then, many efforts have been highlighted to urge state and federal lawmakers to enact a bill requiring all incoming hospital patients be screened for MRSA upon being admitted.

The costs involved when MRSA spreads through a hospital are staggering. The VA Medical Center of Pittsburgh estimated in September 2007 that nearly $35,000 is spent per patient in treatment for MRSA. In addition, the website for the Center for Medicare and Medicaid services states that CMS is analyzing the need to adjust reimbursements for hospital-acquired infections such as MRSA.

"With the urgency currently associated with the MRSA screening, it is critical that hospitals are able to implement screening tests with the appropriate level of quality control," said Michael J. Eck, President and CEO of AcroMetrix. "Many critical and costly treatment decisions will be based on the results of these tests so it is important for patients that the tests are properly monitored during all phases of the testing procedure."

Each lab can help to maintain CLIA compliance for qualitative PCR tests such as those used to detect MRSA DNA by using the OptiQual MRSA Positive Control daily. These controls contain inactivated whole MRSA bacteria, providing a safer method of monitoring the entire PCR process, from extraction through amplification and detection. Convenient and ready to use, the OptiQual MRSA Positive Control is stored at refrigerated temperatures. This product is for Research Use Only. Not for use in diagnostic procedures.

OptiQual(R) is a registered trademark of AcroMetrix.

About AcroMetrix

AcroMetrix, with facilities in Benicia, California and Alkmaar, The Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. All AcroMetrix procedures are developed and manufactured under cGMP, following applicable FDA and ISO/EC standards. For more information on AcroMetrix please visit the company web site at

SOURCE AcroMetrix
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AcroMetrix Announces Launch of PeliSpy Chagas Positive Control
2. Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
3. Laerdal Medical Announces Strategic Relationship
4. Almost Family Announces Acquisition of Apex Home Health
5. Methodist Healthcare - Memphis Hospitals Announces the Extension of Tender Offers
6. Announces Distribution of Wireless Healthcare Research
7. Announces Distribution of CarbonFree Research
8. LCA-Vision Announces the Opening of its 75th LasikPlus(R) Vision Center in Tulsa, Oklahoma
9. MedCom Announces Card Activation Wins Significant Court Ruling
10. Tempo Participacoes S.A. Announces Increase of 16.8% in Net Revenue and of 46.3% in EBITDA for 2007
11. Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007
Post Your Comments:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: